MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm11154537

Медицинская библиотека · Journal of clinical medicine · 2022

Single-Center 20-Year Experience in Surgical Treatment of Malignant Pleural Mesothelioma.

Mangiameli Giuseppe, Bottoni Edoardo, Cariboni Umberto, Ferraroli Giorgio Maria, Morenghi Emanuela, Giudici Veronica Maria, Voulaz Emanuele, Alloisio Marco, Testori Alberto

СтатьяПеревод пока не подготовлен

Аннотация

Objectives

We examined a series of malignant pleural mesothelioma (MPM) patients who consecutively underwent surgery in our institution during the last 20 years. Across this period, we changed our surgical approach to MPM, adopting extended pleurectomy and decortication (eP/D) instead of extrapleural pneumonectomy (EPP). In this study, we compare the perioperative outcomes and long-term survival of patients who underwent EPP vs. eP/D.

Methods

A retrospective analysis was carried out of all the MPM patients identified from our departmental database who underwent EPP or P/D from 2000 to 2021. Clavien−Dindo criteria was adopted to score postoperative complications, while Kaplan−Meier methods and a Cox multivariable analysis were used to perform the survival analysis.

Results

Of 163 patients, 78 (48%) underwent EPP and 85 (52%) eP/D. Induction chemotherapy was significantly administrated more often in the eP/D group (88% vs. 51%). Complete trimodality treatment including induction chemotherapy, radical surgery, and adjuvant radiotherapy was administered in 74% of the eP/D group versus 32% of the EPP group (p < 0.001). The postoperative morbidity rate was higher in the eP/D group (54%) compared to the EPP group (36%) (p = 0.02); no statistically significant differences were identified concerning major complications (EPP 43% vs. eP/D 24%, p = 0.08). No statistical differences were identified in 30-day mortality, 90-day mortality, median disease-free, and overall survival statistics between the two groups. The Cox multivariable analysis confirmed no induction chemotherapy (HR, 0.5; p = 0.002), RDW (HR, 1.08; p = 0.02), and the presence of pathological nodal disease (HR, 1.99; p = 0.001) as factors associated with worse survival in the entire series.

Conclusions

Our data support that eP/D is a well-tolerated procedure allowing the implementation of a trimodality strategy (induction chemotherapy, surgery, and radiotherapy) in most MPM patients. When eP/D is offered in this setting, the oncological results are comparable to EPP. To obtain the best oncological results, the goal of surgical resection should be macroscopic complete resection (R0) in carefully selected patients (clinical N0).

Для цитирования: Mangiameli Giuseppe, Bottoni Edoardo, Cariboni Umberto, Ferraroli Giorgio Maria, Morenghi Emanuela, Giudici Veronica Maria, Voulaz Emanuele, Alloisio Marco, Testori Alberto. Single-Center 20-Year Experience in Surgical Treatment of Malignant Pleural Mesothelioma.. Journal of clinical medicine. 2022. DOI: 10.3390/jcm11154537.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.